Patterns of Growth Factor Costs in Multiple Myeloma Patients Treated With Lenalidomide or Bortezomib

Authors :: J. Lee
Yasir Nagarwala
Andy Surinach
X.H. Hu
Mohamad A. Hussein
Saad Z. Usmani
Gary Binder
Steven R. Arikian
A. Nyandege
Frank A. Corvino
Source :: Clinical Lymphoma Myeloma and Leukemia. 15:e259-e260
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Bortezomib
business.industry
Growth factor
medicine.medical_treatment
Hematology
medicine.disease
Internal medicine
medicine
business
Multiple myeloma
medicine.drug
Lenalidomide

Full Text Access

Tools